Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Study of TAVO412 in Patients with Cancer (TAVO412)
- First Posted Date
- 2025-01-07
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Tavotek Biotherapeutics
- Target Recruit Count
- 50
- Registration Number
- NCT06761651
- Locations
- 🇨🇳
Affiliated Cancer Hospital of Chongqing University, Chongqing, Chongqing, China
🇨🇳First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
🇨🇳Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
A Study of TAVO101 in Atopic Dermatitis Patients
- First Posted Date
- 2023-12-19
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Tavotek Biotherapeutics
- Target Recruit Count
- 20
- Registration Number
- NCT06176040
- Locations
- 🇦🇺
Royal Melbourne Hospital, Parkville, Victoria, Australia
🇳🇿Optimal Clinical Trials, Auckland, New Zealand
A Study of TAVO412 in Patients with Cancer
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Tavotek Biotherapeutics
- Target Recruit Count
- 50
- Registration Number
- NCT05548634
- Locations
- 🇺🇸
Tisch Cancer Center, NYC, New York, United States
Study of TAVO103A in Healthy Volunteers
- First Posted Date
- 2022-04-06
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Tavotek Biotherapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT05313152
- Locations
- 🇺🇸
ICON, Salt Lake City, Utah, United States
Study of TAVO101 in Healthy Volunteers
- Conditions
- Healthy Subjects
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Tavotek Biotherapeutics
- Target Recruit Count
- 42
- Registration Number
- NCT05298046
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia